HPV vaccine coverage is increasing in Australia

Julia ML Brotherton, Karen L Winch, Lisette Bicknell, Genevieve Chappell and Marion Saville
Med J Aust 2017; 206 (6): . || doi: 10.5694/mja16.00958
Published online: 3 April 2017

In 2016, the tenth year of quadrivalent human papillomavirus (HPV) vaccine delivery in Australia by the national immunisation program, it is encouraging to report recent increases in HPV vaccine coverage recorded by the National HPV Vaccination Program Register (NHVPR). The program commenced in April 2007, with a catch-up program for all females aged 12–26 years until the end of 2009, and routine school vaccination at age 12–13 thereafter. In 2013, routine immunisation of boys (12–13 years) against HPV commenced, with a 2-year catch-up program for boys up to 15 years old. Quadrivalent HPV vaccine is routinely given at school to both girls and boys aged 12–13 years, with a three-dose schedule. The NHVPR maintains records of HPV vaccinations, and there is almost complete notification of school doses. Coverage is routinely reported at age 15, as recommended by the World Health Organization and to facilitate consistency in national reporting (the age of vaccination and course completion varies slightly between states and territories). The NHVPR uses Australian Bureau of Statistics estimated resident population data as the denominator for calculating coverage. Notification of doses delivered in general practice is not compulsory, resulting in some undernotification.1

  • Julia ML Brotherton
  • Karen L Winch
  • Lisette Bicknell
  • Genevieve Chappell
  • Marion Saville

  • National HPV Vaccination Program Register, Victorian Cytology Service, Melbourne, VIC


Competing interests:

Julia Brotherton and Marion Saville have been investigators on investigator-initiated unrestricted research projects partly funded by Seqirus and Merck.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.